Literature DB >> 16322416

Translation of research into practice: why we can't "just do it".

Lee A Green1, Colleen M Seifert.   

Abstract

Translation of new knowledge into practice proceeds through 3 stages, from awareness through acceptance to adoption. Translational research focuses almost exclusively on the first 2 stages. We argue that improving the disappointing results of translation efforts will require a detailed understanding of how adoption takes place. We summarize research in cognitive science that illustrates how accepted "declarative" knowledge (acquired through lectures, reading, and discussion) differs (even down to its locus in the brain) from adopted "procedural" knowledge that is acted on in clinical practice. We suggest strategies that can capitalize on the cognitive processes by which declarative knowledge is proceduralized, as a means of making translation more effective, including (1) structured case-level feedback, automated or from human consultants, during the declarative stage; (2) practice in context early in the procedural stage; and (3) deliberative practice when procedural knowledge has been formed but is still being refined.

Entities:  

Mesh:

Year:  2005        PMID: 16322416     DOI: 10.3122/jabfm.18.6.541

Source DB:  PubMed          Journal:  J Am Board Fam Pract        ISSN: 0893-8652


  30 in total

1.  Implementation of Parent Child Interaction Therapy Within Foster Care: An Attempt to Translate an Evidence-Based Program Within a Local Child Welfare Agency.

Authors:  James Topitzes; Joshua P Mersky; Cheryl B McNeil
Journal:  J Public Child Welf       Date:  2015-01

2.  Endoscopist Specialty Predicts the Likelihood of Recommending Cessation of Colorectal Cancer Screening in Older Adults.

Authors:  Audrey H Calderwood; Joseph C Anderson; Christina M Robinson; Lynn F Butterly
Journal:  Am J Gastroenterol       Date:  2018-11-02       Impact factor: 10.864

3.  Best-practice prevention alone or with conventional or biological caries management for 3- to 7-year-olds: the FiCTION three-arm RCT.

Authors:  Anne Maguire; Jan E Clarkson; Gail Va Douglas; Vicky Ryan; Tara Homer; Zoe Marshman; Elaine McColl; Nina Wilson; Luke Vale; Mark Robertson; Alaa Abouhajar; Richard D Holmes; Ruth Freeman; Barbara Chadwick; Christopher Deery; Ferranti Wong; Nicola Pt Innes
Journal:  Health Technol Assess       Date:  2020-01       Impact factor: 4.014

4.  Shared quality data are associated with increased protamine use and reduced bleeding complications after carotid endarterectomy in the Vascular Study Group of New England.

Authors:  Reshma B Patel; Peter Beaulieu; Karen Homa; Philip P Goodney; Andrew C Stanley; Jack L Cronenwett; David H Stone; Daniel J Bertges
Journal:  J Vasc Surg       Date:  2013-09-05       Impact factor: 4.268

5.  From the Editor.

Authors:  Julie Wegner
Journal:  J Extra Corpor Technol       Date:  2018-03

Review 6.  From evidence to best practice in laboratory medicine.

Authors:  A Rita Horvath
Journal:  Clin Biochem Rev       Date:  2013-08

7.  mHealth approaches to child obesity prevention: successes, unique challenges, and next directions.

Authors:  Eleanor B Tate; Donna Spruijt-Metz; Gillian O'Reilly; Maryalice Jordan-Marsh; Marientina Gotsis; Mary Ann Pentz; Genevieve F Dunton
Journal:  Transl Behav Med       Date:  2013-12       Impact factor: 3.046

8.  Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Authors:  John V Ilekis; Ekaterini Tsilou; Susan Fisher; Vikki M Abrahams; Michael J Soares; James C Cross; Stacy Zamudio; Nicholas P Illsley; Leslie Myatt; Christine Colvis; Maged M Costantine; David M Haas; Yoel Sadovsky; Carl Weiner; Erik Rytting; Gene Bidwell
Journal:  Am J Obstet Gynecol       Date:  2016-03-10       Impact factor: 8.661

Review 9.  The role of human agents in facilitating clinical and translational science.

Authors:  J David Johnson
Journal:  Clin Transl Sci       Date:  2012-02-23       Impact factor: 4.689

10.  Erythropoiesis-stimulating agent use among non-dialysis-dependent CKD patients before and after the trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) using a large US health plan database.

Authors:  Mae Thamer; Yi Zhang; Onkar Kshirsagar; Dennis J Cotter; James S Kaufman
Journal:  Am J Kidney Dis       Date:  2014-07-08       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.